{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:05:31Z","timestamp":1784217931427,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,16]]},"DOI":"10.7759\/cureus.112796","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:34:42Z","timestamp":1784216082000},"source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Biomarkers of Oxidative Stress and Inflammation in Mexican Patients With Type 2 Diabetes and Chronic Kidney Disease"],"prefix":"10.7759","author":[{"given":"Francisco","family":"Mendoza-Carrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Elizabeth","family":"Vazquez-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Parra-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Orozco-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"Salazar-Soltero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes del Carmen","family":"Rizo-de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caridad Aurea","family":"Leal-Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad E","year":"2022","unstructured":"Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet. 2022, 400:1803-20. 10.1016\/S0140-6736(22)01655-5","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21149\/17286","article-title":"Prevalence of diabetes and glycemic control in Mexico, Ensanut 2021-2024","volume":"67","author":"Reyes-Garc\u00eda A","year":"2025","unstructured":"Reyes-Garc\u00eda A, Basto-Abreu A, Reyes-S\u00e1nchez F, et al.. Prevalence of diabetes and glycemic control in Mexico, Ensanut 2021-2024. Salud Publica Mex. 2025, 67:622-32. 10.21149\/17286","journal-title":"Salud Publica Mex"},{"key":"ref3","unstructured":"System USRD. 2021 USRDS annual data report. (2021). Accessed: December 18, 2025: https:\/\/usrds-adr.niddk.nih.gov\/2021\/end-stage-renal-disease\/11-international-comparisons."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2022.0041","article-title":"Association of variants of the NFE2L2 gene with metabolic and kidney function parameters in patients with diabetes and\/or hypertension","volume":"26","author":"G\u00f3mez-Garc\u00eda EF","year":"2022","unstructured":"G\u00f3mez-Garc\u00eda EF, Cort\u00e9s-Sanabria L, Cueto-Manzano AM, et al.. Association of variants of the NFE2L2 gene with metabolic and kidney function parameters in patients with diabetes and\/or hypertension. Genet Test Mol Biomarkers. 2022, 26:382-90. 10.1089\/gtmb.2022.0041","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1258\/0004563053492838","article-title":"Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria","volume":"42","author":"Ozdemir G","year":"2005","unstructured":"Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Ann Clin Biochem. 2005, 42:99-104. 10.1258\/0004563053492838","journal-title":"Ann Clin Biochem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.389","article-title":"The association of oxidative stress biomarkers with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"4","author":"Banik S","year":"2021","unstructured":"Banik S, Ghosh A. The association of oxidative stress biomarkers with type 2 diabetes mellitus: a systematic review and meta-analysis. Health Sci Rep. 2021, 4:e389. 10.1002\/hsr2.389","journal-title":"Health Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097898","article-title":"Mechanisms of oxidative stress in metabolic syndrome","volume":"24","author":"Masenga SK","year":"2023","unstructured":"Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci. 2023, 24:7898. 10.3390\/ijms24097898","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27754","article-title":"Novel biomarkers related to oxidative stress and immunity in chronic kidney disease","volume":"10","author":"Bai F","year":"2024","unstructured":"Bai F, Wang C, Fan X, et al.. Novel biomarkers related to oxidative stress and immunity in chronic kidney disease. Heliyon. 2024, 10:e27754. 10.1016\/j.heliyon.2024.e27754","journal-title":"Heliyon"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26097","article-title":"Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked?","volume":"118","author":"Rehman K","year":"2017","unstructured":"Rehman K, Akash MS. Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked?. J Cell Biochem. 2017, 118:3577-85. 10.1002\/jcb.26097","journal-title":"J Cell Biochem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13040455","article-title":"Oxidative stress: a culprit in the progression of diabetic kidney disease","volume":"13","author":"Wang N","year":"2024","unstructured":"Wang N, Zhang C. Oxidative stress: a culprit in the progression of diabetic kidney disease. Antioxidants (Basel). 2024, 13:455. 10.3390\/antiox13040455","journal-title":"Antioxidants (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161025234","article-title":"Diabetic cardiovascular disease induced by oxidative stress","volume":"16","author":"Kayama Y","year":"2015","unstructured":"Kayama Y, Raaz U, Jagger A, et al.. Diabetic cardiovascular disease induced by oxidative stress. Int J Mol Sci. 2015, 16:25234-63. 10.3390\/ijms161025234","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.34067\/kid.0000962019","article-title":"Vascular dysfunction, oxidative stress, and inflammation in chronic kidney disease","volume":"1","author":"Nowak KL","year":"2020","unstructured":"Nowak KL, Jovanovich A, Farmer-Bailey H, et al.. Vascular dysfunction, oxidative stress, and inflammation in chronic kidney disease. Kidney360. 2020, 1:501-9. 10.34067\/kid.0000962019","journal-title":"Kidney360"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4421","article-title":"Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE","volume":"6","author":"Wong FN","year":"2018","unstructured":"Wong FN, Chua KH, Tan JA, Wong CM, Kuppusamy UR. Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE. PeerJ. 2018, 6:e4421. 10.7717\/peerj.4421","journal-title":"PeerJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2019.6.01","article-title":"Oxidative stress and inflammatory markers in prediabetes and diabetes","volume":"70","author":"Luc K","year":"2019","unstructured":"Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP. Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol. 2019, 70:809-24. 10.26402\/jpp.2019.6.01","journal-title":"J Physiol Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05818-z","article-title":"Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications","volume":"15","author":"Cecerska-Hery\u0107 E","year":"2025","unstructured":"Cecerska-Hery\u0107 E, Engwert W, Micha\u0142\u00f3w J, et al.. Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications. Sci Rep. 2025, 15:23605. 10.1038\/s41598-025-05818-z","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms151120290","article-title":"Nrf2 and redox status in prediabetic and diabetic patients","volume":"15","author":"Jim\u00e9nez-Osorio AS","year":"2014","unstructured":"Jim\u00e9nez-Osorio AS, Picazo A, Gonz\u00e1lez-Reyes S, Barrera-Oviedo D, Rodr\u00edguez-Arellano ME, Pedraza-Chaverri J. Nrf2 and redox status in prediabetic and diabetic patients. Int J Mol Sci. 2014, 15:20290-305. 10.3390\/ijms151120290","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2015.39.1.59","article-title":"Myeloperoxidase is associated with insulin resistance and inflammation in overweight subjects with first-degree relatives with type 2 diabetes mellitus","volume":"39","author":"G\u00f3mez Garc\u00eda A","year":"2015","unstructured":"G\u00f3mez Garc\u00eda A, Rivera Rodr\u00edguez M, G\u00f3mez Alonso C, Rodr\u00edguez Ochoa DY, Alvarez Aguilar C. Myeloperoxidase is associated with insulin resistance and inflammation in overweight subjects with first-degree relatives with type 2 diabetes mellitus. Diabetes Metab J. 2015, 39:59-65. 10.4093\/dmj.2015.39.1.59","journal-title":"Diabetes Metab J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911196","article-title":"The influence of the severity of early chronic kidney disease on oxidative stress in patients with and without type 2 diabetes mellitus","volume":"23","author":"Andrade-Sierra J","year":"2022","unstructured":"Andrade-Sierra J, Pazar\u00edn-Villase\u00f1or L, Yanowsky-Escatell FG, et al.. The influence of the severity of early chronic kidney disease on oxidative stress in patients with and without type 2 diabetes mellitus. Int J Mol Sci. 2022, 23:11196. 10.3390\/ijms231911196","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020, 43:S14-31. 10.2337\/dc20-S002","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.64","article-title":"Chapter 1: definition and classification of CKD","volume":"3","author":"Kidney Disease: Improving Global Outcomes","year":"2013","unstructured":"Kidney Disease. Improving Global Outcomes: Chapter 1: definition and classification of CKD. Kidney Int Suppl (2011). 2013, 3:19-62. 10.1038\/kisup.2012.64","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000597","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"138","author":"Whelton PK","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al.. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation. 2018, 138:e426-83. 10.1161\/CIR.0000000000000597","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201708007","article-title":"Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling","volume":"217","author":"Wang Y","year":"2018","unstructured":"Wang Y, Branicky R, No\u00eb A, Hekimi S. Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol. 2018, 217:1915-28. 10.1083\/jcb.201708007","journal-title":"J Cell Biol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00401.2017","article-title":"Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy","volume":"316","author":"Kuo CW","year":"2019","unstructured":"Kuo CW, Chen HL, Tu MY, Chen CM. Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy. Am J Physiol Renal Physiol. 2019, 316:F32-41. 10.1152\/ajprenal.00401.2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122813","article-title":"NLRP3 inflammasome: a central player in renal pathologies and nephropathy","volume":"351","author":"Henedak NT","year":"2024","unstructured":"Henedak NT, El-Abhar HS, Soubh AA, Abdallah DM. NLRP3 inflammasome: a central player in renal pathologies and nephropathy. Life Sci. 2024, 351:122813. 10.1016\/j.lfs.2024.122813","journal-title":"Life Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00755","article-title":"Manganese superoxide dismutase dysfunction and the pathogenesis of kidney disease","volume":"11","author":"Kitada M","year":"2020","unstructured":"Kitada M, Xu J, Ogura Y, Monno I, Koya D. Manganese superoxide dismutase dysfunction and the pathogenesis of kidney disease. Front Physiol. 2020, 11:755. 10.3389\/fphys.2020.00755","journal-title":"Front Physiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-025-01153-6","article-title":"From kidney injury to cardiac dysfunction: the central role of oxidative stress in diabetes and CKD","volume":"121","author":"Sen P","year":"2026","unstructured":"Sen P, Sittig T, Hamers J, et al.. From kidney injury to cardiac dysfunction: the central role of oxidative stress in diabetes and CKD. Basic Res Cardiol. 2026, 121:93-112. 10.1007\/s00395-025-01153-6","journal-title":"Basic Res Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010263","article-title":"Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites","volume":"21","author":"Rapa SF","year":"2019","unstructured":"Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci. 2019, 21:263. 10.3390\/ijms21010263","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/500034-analysis-of-biomarkers-of-oxidative-stress-and-inflammation-in-mexican-patients-with-type-2-diabetes-and-chronic-kidney-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:34:44Z","timestamp":1784216084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/500034-analysis-of-biomarkers-of-oxidative-stress-and-inflammation-in-mexican-patients-with-type-2-diabetes-and-chronic-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.112796","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}